Peripheral neuropathy induced by subcutaneous bortezomib-based induction therapy for newly diagnosed multiple myeloma

Por Brioli, Annamaria, Zannetti, Beatrice Anna, Zamagni, Elena, Tacchetti, Paola, Pantani, Lucia, Mancuso, Katia, Pezzi, Annalisa, Rocchi, Serena, Cavo, Michele
Publicado no Haematologica (2014)

Role of serum free light chain assay in the detection of early relapse and prediction of prognosis after relapse in multiple myeloma patients treated upfront with novel agents

Por Tacchetti, Paola, Pezzi, Annalisa, Zamagni, Elena, Pantani, Lucia, Rocchi, Serena, Zannetti, Beatrice Anna, Mancuso, Katia, Rizzello, Ilaria, Cavo, Michele
Publicado no Haematologica (2017)

The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD)

Por Terragna, Carolina, Remondini, Daniel, Martello, Marina, Zamagni, Elena, Pantani, Lucia, Patriarca, Francesca, Pezzi, Annalisa, Levi, Giuseppe, Offidani, Massimo, Proserpio, Ilaria, De Sabbata, Giovanni, Tacchetti, Paola, Cangialosi, Clotilde, Ciambelli, Fabrizio, Viganò, Clara Virginia, Dico, Flores Angela, Santacroce, Barbara, Borsi, Enrica, Brioli, Annamaria, Marzocchi, Giulia, Castellani, Gastone, Martinelli, Giovanni, Palumbo, Antonio, Cavo, Michele
Publicado no Oncotarget (2015)